Least developed countries vs Sri Lanka: Immunization, Hib3
Least developed countries
74.4%
in 2024
Sri Lanka
97.0%
in 2024
Least developed countries rank
30th
Sri Lanka rank
29th
Immunization, Hib3 over time
- Least developed countries
- Sri Lanka
How they compare
Sri Lanka currently reports 97.0% against 74.4% in Least developed countries, a difference of 22.6%.
That makes Sri Lanka's figure about 1.3 times Least developed countries's.
Across all 15 years both countries report, Sri Lanka has been ahead every year.
Least developed countries ranks 30th and Sri Lanka ranks 29th of 43 groups.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Least developed countries | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.5% | 99.0% | 23.5% | Sri Lanka |
| 2020s | 74.4% | 97.2% | 22.8% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Least developed countries or Sri Lanka?
- Sri Lanka, at 97.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hib3 between Least developed countries and Sri Lanka?
- 22.6%, with Sri Lanka ahead.
- How many years of comparable data are there for Least developed countries and Sri Lanka?
- 15 years are reported by both, from 2010 to 2024.
- How do Least developed countries and Sri Lanka rank globally for immunization, hib3?
- Least developed countries ranks 30th and Sri Lanka ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.